ST2859 serogroup a meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: A prospective study

Tropical Medicine and International Health

Volumn 13, Issue 6, 2008, Pages 861-868

  Sie A ^b   Pfluger V ^c   Coulibaly, B ^b   Dangy, J P ^c   Kapaun, A ^a   Junghanss, T ^a   Pluschke, G ^c   Leimkugel, J ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b CENTRE DE RECHERCHE EN SANTÉ DE NOUNA   (Burkina Faso)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Meningococcal meningitis; Neisseria meningitidis serogroup A

Indexed keywords

BACTERIAL DISEASE; COLONIZATION; DISEASE INCIDENCE; DISEASE SPREAD; EPIDEMIOLOGY; MENINGITIS; VIRULENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL STRAIN; BLOOD GROUP TYPING; BURKINA FASO; CEREBROSPINAL FLUID ANALYSIS; CHILD; CONTROLLED STUDY; EPIDEMIC MENINGITIS; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; NEWBORN; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BACTERIAL TYPING TECHNIQUES; BURKINA FASO; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; INFANT, NEWBORN; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP A; PROSPECTIVE STUDIES;

AFRICA; BURKINA FASO; NOUNA; SUB-SAHARAN AFRICA; WEST AFRICA;

NEISSERIA MENINGITIDIS SEROGROUP A;

EID: 43549118365     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02056.x     Document Type: Article

References (31)

1. Bennett DE, Mulhall RM Cafferkey MT (2004) PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. Journal of Clinical Microbiology 42, 1764 1765.
2. Bilukha OO Rosenstein N (2005) Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Report 54, 1 21.
3. Boisier P, Nicolas P, Djibo S et al. (2007) Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infectious Diseases 44, 657 663.
4. Claus H, Maiden MC, Wilson DJ et al. (2005) Genetic analysis of meningococci carried by children and young adults. The Journal of Infectious Diseases 191, 1263 1271.
5. Djibo S, Nicolas P, Alonso JM et al. (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Tropical Medicine and International Health 8, 1118 1123.
6. ECD Nouna (2005) Plan d'action 2006. District Sanitaire de Nouna.
7. Fonkoua MC, Taha MK, Nicolas P et al. (2002) Recent increase in meningitis caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. Emerging Infectious Diseases 8, 327 329.
8. Gagneux S, Hodgson A, Ehrhard I et al. (2000) Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Tropical Medicine and International Health 5, 280 287.
9. Gagneux SP, Hodgson A, Smith TA et al. (2002) Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. The Journal of Infectious Diseases 185, 618 626.
10. Greenwood B (1999) Manson Lecture. Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 341 353.
11. Greenwood B (2007) The changing face of meningococcal disease in West Africa. Epidemiology and Infection 135, 703 705.
12. Harrison LH, Jolley KA, Shutt KA et al. (2006) Antigenic shift and increased incidence of meningococcal disease. The Journal of Infectious Diseases 193, 1266 1274.
13. Leimkugel J, Hodgson A, Forgor AA et al. (2007a) Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Medicine 4, 0535 0544.
14. Leimkugel J, Forgor AA, Dangy JP et al. (2007b) Genetic diversification of Neisseria meningitidis during waves of colonization and disease in the meningitis belt of sub-Saharan Africa. Vaccine 25S, A18 23.
15. Mueller JE, Sangare L, Njanpop-Lafourcade BM et al. (2007) Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. Emerging Infectious Diseases 13, 847 854.
16. Nicolas P, Decousset L, Riglet V et al. (2001) Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerging Infectious Diseases 7, 849 854.
17. Nicolas P, Norheim G, Garnotel E, Djibo S Caugant DA (2005) Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. Journal of Clinical Microbiology 43, 5129 5135.
18. Njanpop-Lafourcade BM, Parent DCI, Sanou O, Alonso JM Taha MK (2005) The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso. Microbes and Infection 7, 645 649.
19. Parent DCI, Traore Y, Gessner BD et al. (2005) Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clinical Infectious Diseases 40, 17 25.
20. Peltola H (2001) Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clinical Infectious Diseases 32, 64 75.
21. Taha MK (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 38, 855 857.
22. Taha MK, Achtman M, Alonso JM et al. (2000) Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356, 2159.
23. Taha MK, Parent DCI, Schlumberger M et al. (2002) Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. Journal of Clinical Microbiology 40, 1083 1084.
24. Teyssou R Muroz-Le Rouzic E (2007) Meningitis in Africa: a brief overview. Vaccine 25S, A3 A9.
25. Traore Y, Njanpop-Lafourcade BM, Adjogble KL et al. (2006) The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clinical Infectious Diseases 43, 817 822.
26. Tsang RS, Henderson AM, Cameron ML et al. (2007) Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada. Journal of Clinical Microbiology 45, 1753 1758.
27. Whittle HC, Evans-Jones G, Onyewotu I et al. (1975) Letter: Group-C Meningococcal meningitis in the northern Savanna of Africa. Lancet i, 1377.
28. WHO (1999) Laboratory Methods for the Diagnosis of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO, Geneva.
29. WHO (2007) Risk of epidemic meningitis in Africa: a cause for concern. Weekly Epidemiological Record 82, 79 87.
30. Yazdankhah SP, Kriz P, Tzanakaki G et al. (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. Journal of Clinical Microbiology 42, 5146 5153.
31. Ye Y, Gbangou A Koyaté B (2002) Nouna DSS, Burkina Faso. in: Population and Health (ed. INDEPTH) International Development Research Center, Ottawa, pp. 221 226.